메뉴 건너뛰기




Volumn 18, Issue 4, 2012, Pages 459-465

From the prodrome to chronic schizophrenia: The neurobiology underlying psychotic symptoms and cognitive impairments

Author keywords

Antipsychotic; Cognition; Etiology; Functional imaging; Imaging; Mechanisms; MRI; PET; Prodrome; Psychosis; Schizophrenia; SPECT; SPET; Treatment

Indexed keywords

DOPAMINE; N METHYL DEXTRO ASPARTIC ACID; PK 1195; PK 1195 C 11; SEROTONIN 5 RECEPTOR; TRACER; UNCLASSIFIED DRUG; WAY 100632; WAY 100632 C 11;

EID: 84856513745     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/138161212799316217     Document Type: Review
Times cited : (46)

References (95)
  • 1
    • 0026436979 scopus 로고
    • Schizophrenia: Manifestations, incidence and course in different cultures. A World Health Organization ten-country study
    • Jablensky A, Sartorius N, Ernberg G, et al. Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study. Psychol Med Monogr Suppl 1992; 20: 1-97.
    • (1992) Psychol Med Monogr Suppl , vol.20 , pp. 1-97
    • Jablensky, A.1    Sartorius, N.2    Ernberg, G.3
  • 2
    • 0034529505 scopus 로고    scopus 로고
    • Epidemiology of schizophrenia: The global burden of disease and disability
    • Jablensky A. Epidemiology of schizophrenia: the global burden of disease and disability. Eur Arch Psychiatry Clin Neurosci 2000; 250(6): 274-85.
    • (2000) Eur Arch Psychiatry Clin Neurosci , vol.250 , Issue.6 , pp. 274-285
    • Jablensky, A.1
  • 4
    • 22144432283 scopus 로고    scopus 로고
    • A systematic review of the prevalence of schizophrenia
    • Saha S, Chant D, Welham J, McGrath J. A systematic review of the prevalence of schizophrenia. PLoS Med 2005; 2(5): e141.
    • (2005) PLoS Med , vol.2 , Issue.5
    • Saha, S.1    Chant, D.2    Welham, J.3    McGrath, J.4
  • 5
    • 33646042532 scopus 로고    scopus 로고
    • Perspectives: An international review of the national cost estimates of mental illness, 1990-2003
    • Hu TW. Perspectives: an international review of the national cost estimates of mental illness, 1990-2003. J Ment Health Policy Econ 2006; 9(1):3-13.
    • (2006) J Ment Health Policy Econ , vol.9 , Issue.1 , pp. 3-13
    • Hu, T.W.1
  • 6
    • 0033064214 scopus 로고    scopus 로고
    • An incidence-based cost-of-illness model for the first 5 years following diagnosis
    • Cost of schizophrenia to UK Society
    • Guest JF, Cookson RF. Cost of schizophrenia to UK Society. An incidence-based cost-of-illness model for the first 5 years following diagnosis. Pharmacoeconomics 1999; 15(6): 597-610.
    • (1999) Pharmacoeconomics , vol.15 , Issue.6 , pp. 597-610
    • Guest, J.F.1    Cookson, R.F.2
  • 7
    • 1842858243 scopus 로고    scopus 로고
    • The global costs of schizophrenia
    • Knapp M, Mangalore R, Simon J. The global costs of schizophrenia. Schizophr Bull 2004; 30(2): 279-93.
    • (2004) Schizophr Bull , vol.30 , Issue.2 , pp. 279-293
    • Knapp, M.1    Mangalore, R.2    Simon, J.3
  • 8
    • 0033599714 scopus 로고    scopus 로고
    • Schizophrenia
    • Schultz SK, Andreasen NC. Schizophrenia. Lancet 1999; 353(9162):1425-30.
    • (1999) Lancet , vol.353 , Issue.9162 , pp. 1425-1430
    • Schultz, S.K.1    Andreasen, N.C.2
  • 9
    • 9644294583 scopus 로고    scopus 로고
    • Course and long-term treatment of schizophrenic psychoses
    • Moller HJ. Course and long-term treatment of schizophrenic psychoses. Pharmacopsychiatry 2004; 37 (Suppl 2):126-135.
    • (2004) Pharmacopsychiatry , vol.37 , Issue.SUPPL. 2 , pp. 126-135
    • Moller, H.J.1
  • 10
    • 34548028742 scopus 로고    scopus 로고
    • Cognitive functioning in the schizophrenia prodrome
    • Simon AE, Cattapan-Ludewig K, Zmilacher S, et al. Cognitive functioning in the schizophrenia prodrome. SchizophrBull. 2007; 33(3): 761-71.
    • (2007) SchizophrBull , vol.33 , Issue.3 , pp. 761-771
    • Simon, A.E.1    Cattapan-Ludewig, K.2    Zmilacher, S.3
  • 13
    • 33748474553 scopus 로고    scopus 로고
    • Pathophysiologically based treatment interventions in schizophrenia
    • Lewis DA, Gonzalez-Burgos G. Pathophysiologically based treatment interventions in schizophrenia. Nat Med 2006; 12(9): 1016-22
    • (2006) Nat Med , vol.12 , Issue.9 , pp. 1016-1022
    • Lewis, D.A.1    Gonzalez-Burgos, G.2
  • 14
    • 38749140981 scopus 로고    scopus 로고
    • Functional neuroimaging in schizophrenia: Diagnosis and drug discovery
    • McGuire P, Howes OD, Stone J, Fusar-Poli P. Functional neuroimaging in schizophrenia: diagnosis and drug discovery. Trends Pharmacol Sci 2008; 29(2): 91-8.
    • (2008) Trends Pharmacol Sci , vol.29 , Issue.2 , pp. 91-98
    • McGuire, P.1    Howes, O.D.2    Stone, J.3    Fusar-Poli, P.4
  • 15
    • 37249083413 scopus 로고    scopus 로고
    • Molecular imaging studies of the striatal dopaminergic system in psychosis and predictions for the prodromal phase of psychosis
    • Howes OD, Montgomery AJ, Asselin MC, Murray RM, Grasby PM, McGuire PK. Molecular imaging studies of the striatal dopaminergic system in psychosis and predictions for the prodromal phase of psychosis. Br J Psychiatry Suppl 2007; 51: s13-s18
    • (2007) Br J Psychiatry Suppl , vol.51
    • Howes, O.D.1    Montgomery, A.J.2    Asselin, M.C.3    Murray, R.M.4    Grasby, P.M.5    McGuire, P.K.6
  • 16
    • 25444483073 scopus 로고    scopus 로고
    • From dopamine to salience to psychosis-linking biology, pharmacology and phenomenology of psychosis
    • Kapur S, Mizrahi R, Li M. From dopamine to salience to psychosis-linking biology, pharmacology and phenomenology of psychosis. Schizophr Res 2005; 79(1): 59-68.
    • (2005) Schizophr Res , vol.79 , Issue.1 , pp. 59-68
    • Kapur, S.1    Mizrahi, R.2    Li, M.3
  • 17
    • 0023103235 scopus 로고
    • Provocative tests with psychostimulant drugs in schizophrenia
    • Lieberman JA, Kane JM, Alvir J. Provocative tests with psychostimulant drugs in schizophrenia. Psychopharmacology (Berl) 1987; 91(4): 415-33.
    • (1987) Psychopharmacology (Berl) , vol.91 , Issue.4 , pp. 415-433
    • Lieberman, J.A.1    Kane, J.M.2    Alvir, J.3
  • 18
    • 0000428532 scopus 로고
    • 3,4- Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists
    • Carlsson A, Lindqvist M, Magnusson T. 3,4- Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists. Nature 1957; 180(4596): 1200.
    • (1957) Nature , vol.180 , Issue.4596 , pp. 1200
    • Carlsson, A.1    Lindqvist, M.2    Magnusson, T.3
  • 19
    • 0017255979 scopus 로고
    • Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs
    • Creese I, Burt DR, Snyder SH. Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science 1976; 192(4238): 481-3.
    • (1976) Science , vol.192 , Issue.4238 , pp. 481-483
    • Creese, I.1    Burt, D.R.2    Snyder, S.H.3
  • 20
    • 0017068246 scopus 로고
    • Antipsychotic drug doses and neuroleptic/dopamine receptors
    • Seeman P, Lee T, Chau-Wong M, Wong K. Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature 1976; 261(5562): 717-9.
    • (1976) Nature , vol.261 , Issue.5562 , pp. 717-719
    • Seeman, P.1    Lee, T.2    Chau-Wong, M.3    Wong, K.4
  • 21
    • 0015581657 scopus 로고
    • Antipsychotic drug actions: A clue to the neuropathology of schizophrenia?
    • Matthysse S. Antipsychotic drug actions: a clue to the neuropathology of schizophrenia? Fed Proc 1973; 32(2): 200-5.
    • (1973) Fed Proc , vol.32 , Issue.2 , pp. 200-205
    • Matthysse, S.1
  • 22
    • 0017277759 scopus 로고
    • The dopamine hypothesis of schizophrenia: Focus on the dopamine receptor
    • Snyder SH. The dopamine hypothesis of schizophrenia: focus on the dopamine receptor. Am J Psychiatry 1976; 133(2): 197-202.
    • (1976) Am J Psychiatry , vol.133 , Issue.2 , pp. 197-202
    • Snyder, S.H.1
  • 23
    • 0031791214 scopus 로고    scopus 로고
    • Imaging dopamine transmission in schizophrenia. A review and meta-analysis
    • Laruelle M. Imaging dopamine transmission in schizophrenia. A review and meta-analysis. Q J Nucl Med 1998; 42(3): 211-21.
    • (1998) Q J Nucl Med , vol.42 , Issue.3 , pp. 211-221
    • Laruelle, M.1
  • 24
    • 0034774737 scopus 로고    scopus 로고
    • Dopamine receptors in the brains of schizophrenia patients: A meta-analysis of the findings
    • Kestler LP, Walker E, Vega EM. Dopamine receptors in the brains of schizophrenia patients: a meta-analysis of the findings. Behav Pharmacol 2001; 12(5): 355-71.
    • (2001) Behav Pharmacol , vol.12 , Issue.5 , pp. 355-371
    • Kestler, L.P.1    Walker, E.2    Vega, E.M.3
  • 25
    • 0031037346 scopus 로고    scopus 로고
    • Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET
    • Okubo Y, Suhara T, Suzuki K, et al. Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET. Nature 1997; 385(6617): 634-6.
    • (1997) Nature , vol.385 , Issue.6617 , pp. 634-636
    • Okubo, Y.1    Suhara, T.2    Suzuki, K.3
  • 26
    • 0036242723 scopus 로고    scopus 로고
    • PET study of D(1) dopamine receptor binding in neuroleptic-naive patients with schizophrenia
    • Karlsson P, Farde L, Halldin C, Sedvall G. PET study of D(1) dopamine receptor binding in neuroleptic-naive patients with schizophrenia. Am J Psychiatry 2002; 159(5): 761-7.
    • (2002) Am J Psychiatry , vol.159 , Issue.5 , pp. 761-767
    • Karlsson, P.1    Farde, L.2    Halldin, C.3    Sedvall, G.4
  • 27
    • 33746575616 scopus 로고    scopus 로고
    • Psychosis pathways converge via D2high dopamine receptors
    • Seeman P, Schwarz J, Chen JF, et al. Psychosis pathways converge via D2high dopamine receptors. Synapse 2006; 60(4):319-46.
    • (2006) Synapse , vol.60 , Issue.4 , pp. 319-346
    • Seeman, P.1    Schwarz, J.2    Chen, J.F.3
  • 28
    • 59949098994 scopus 로고    scopus 로고
    • The dopamine D2 receptors in high-affinity state and D3 receptors in schizophrenia: A clinical [11C]-(+)-PHNO PET study
    • Graf-Guerrero A, Romina M, Agid O, et al. The dopamine D2 receptors in high-affinity state and D3 receptors in schizophrenia: a clinical [11C]-(+)-PHNO PET study. Neuropsychopharmacology 2009; 34(4): 1078-86.
    • (2009) Neuropsychopharmacology , vol.34 , Issue.4 , pp. 1078-1086
    • Graf-Guerrero, A.1    Romina, M.2    Agid, O.3
  • 29
    • 0142134118 scopus 로고    scopus 로고
    • Monoamine neuron innervation of the normal human brain: An 18F-DOPA PET study
    • Moore RY, Whone AL, McGowan S, Brooks DJ. Monoamine neuron innervation of the normal human brain: an 18F-DOPA PET study. Brain Res 2003; 982(2): 137-45.
    • (2003) Brain Res , vol.982 , Issue.2 , pp. 137-145
    • Moore, R.Y.1    Whone, A.L.2    McGowan, S.3    Brooks, D.J.4
  • 30
    • 69249145260 scopus 로고    scopus 로고
    • Mechanisms underlying psychosis and antipsychotic treatment response in schizophrenia: Insights from PET and SPECT imaging
    • Howes OD, Egerton A, Allan V, McGuire P, Stokes P, Kapur S. Mechanisms underlying psychosis and antipsychotic treatment response in schizophrenia: insights from PET and SPECT imaging. Curr Pharm Des 2009; 15(22): 2550-9.
    • (2009) Curr Pharm Des , vol.15 , Issue.22 , pp. 2550-2559
    • Howes, O.D.1    Egerton, A.2    Allan, V.3    McGuire, P.4    Stokes, P.5    Kapur, S.6
  • 31
    • 0031799667 scopus 로고    scopus 로고
    • Increased striatal dopamine transmission in schizophrenia: Confirmation in a second cohort
    • Abi-Dargham A, Gil R, Krystal J, et al. Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort. Am J Psychiatry 1998; 155(6): 761-7.
    • (1998) Am J Psychiatry , vol.155 , Issue.6 , pp. 761-767
    • Abi-Dargham, A.1    Gil, R.2    Krystal, J.3
  • 32
    • 12644293806 scopus 로고    scopus 로고
    • Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: Evidence from a novel positron emission tomography method
    • Breier A, Su TP, Saunders R, et al. Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. Proc Natl Acad Sci U S A 1997; 94(6): 2569-74.
    • (1997) Proc Natl Acad Sci U S A , vol.94 , Issue.6 , pp. 2569-2574
    • Breier, A.1    Su, T.P.2    Saunders, R.3
  • 33
    • 0029787944 scopus 로고    scopus 로고
    • Single photon emission computerized tomography imaging of amphetamineinduced dopamine release in drug-free schizophrenic subjects
    • Laruelle M, Abi-Dargham A, van Dyck CH, et al. Single photon emission computerized tomography imaging of amphetamineinduced dopamine release in drug-free schizophrenic subjects. Proc Natl Acad Sci U S A 1996; 93(17): 9235-40.
    • (1996) Proc Natl Acad Sci U S A , vol.93 , Issue.17 , pp. 9235-9240
    • Laruelle, M.1    Abi-Dargham, A.2    van Dyck, C.H.3
  • 34
    • 0034608753 scopus 로고    scopus 로고
    • Increased baseline occupancy of D2 receptors by dopamine in schizophrenia
    • Abi-Dargham A, Rodenhiser J, Printz D, et al. Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. Proc Natl Acad Sci U S A 2000; 97(14): 8104-9
    • (2000) Proc Natl Acad Sci U S A , vol.97 , Issue.14 , pp. 8104-8109
    • Abi-Dargham, A.1    Rodenhiser, J.2    Printz, D.3
  • 35
    • 58149489347 scopus 로고    scopus 로고
    • Elevated striatal dopamine function linked to prodromal signs of schizophrenia
    • Howes OD, Montgomery AJ, Asselin MC, et al. Elevated striatal dopamine function linked to prodromal signs of schizophrenia. Arch Gen Psychiatry 2009; 66(1):13-20
    • (2009) Arch Gen Psychiatry , vol.66 , Issue.1 , pp. 13-20
    • Howes, O.D.1    Montgomery, A.J.2    Asselin, M.C.3
  • 36
    • 2342471341 scopus 로고    scopus 로고
    • Striatal amphetamine-induced dopamine release in patients with schizotypal personality disorder studied with single photon emission computed tomography and [123I]iodobenzamide
    • Abi-Dargham A, Kegeles LS, Zea-Ponce Y, et al. Striatal amphetamine-induced dopamine release in patients with schizotypal personality disorder studied with single photon emission computed tomography and [123I]iodobenzamide. Biol Psychiatry 2004; 55(10): 1001-6.
    • (2004) Biol Psychiatry , vol.55 , Issue.10 , pp. 1001-1006
    • Abi-Dargham, A.1    Kegeles, L.S.2    Zea-Ponce, Y.3
  • 37
    • 77649197534 scopus 로고    scopus 로고
    • Increased synaptic dopamine function in associative regions of the striatum in schizophrenia
    • Mar
    • Kegeles LS, Abi-Dargham A, Frankle WG, et al. Increased synaptic dopamine function in associative regions of the striatum in schizophrenia. Arch Gen Psychiatry 2010 Mar;67(3): 231-9.
    • (2010) Arch Gen Psychiatry , vol.67 , Issue.3 , pp. 231-239
    • Kegeles, L.S.1    Abi-Dargham, A.2    Frankle, W.G.3
  • 39
    • 84857099124 scopus 로고    scopus 로고
    • Dopamine synthesis capacity before onset of psychosis: A prospective [18F]-DOPA PET imaging study
    • 2011 Jul 18. [Epub ahead of print] PMID: 21768612
    • Howes OD, Bose S, Valli I, et al. Dopamine synthesis capacity before onset of psychosis: a prospective [18F]-DOPA PET imaging study. Am J Psychiatry 2011 Jul 18. [Epub ahead of print] PMID: 21768612.
    • Am J Psychiatry
    • Howes, O.D.1    Bose, S.2    Valli, I.3
  • 40
    • 80052068381 scopus 로고    scopus 로고
    • Progressive increase in striatal dopamine synthesis capacity as patients develop psychosis: A PET study
    • Howes O, Bose S, Turkheimer F, et al. Progressive increase in striatal dopamine synthesis capacity as patients develop psychosis: a PET study. Mol Psychiatry 2011; 16(9): 885-6.
    • (2011) Mol Psychiatry , vol.16 , Issue.9 , pp. 885-886
    • Howes, O.1    Bose, S.2    Turkheimer, F.3
  • 41
    • 0037223711 scopus 로고    scopus 로고
    • Psychosis as a state of aberrant salience: A framework linking biology, phenomenology, and pharmacology in schizophrenia
    • Kapur S. Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. Am J Psychiatry 2003; 160(1): 13-23
    • (2003) Am J Psychiatry , vol.160 , Issue.1 , pp. 13-23
    • Kapur, S.1
  • 42
    • 56049125680 scopus 로고    scopus 로고
    • Classification of schizophrenic patients and healthy controls using [18F] fluorodopa PET imaging
    • Bose SK, Turkheimer FE, Howes OD, et al. Classification of schizophrenic patients and healthy controls using [18F] fluorodopa PET imaging. Schizophr Res 2008; 106(2-3): 148-55
    • (2008) Schizophr Res , vol.106 , Issue.2-3 , pp. 148-155
    • Bose, S.K.1    Turkheimer, F.E.2    Howes, O.D.3
  • 43
    • 28544436939 scopus 로고    scopus 로고
    • Working memory impairments in schizophrenia: A meta-analysis
    • Lee J, Park S. Working memory impairments in schizophrenia: a meta-analysis. J Abnorm Psychol 2005; 114(4): 599-611.
    • (2005) J Abnorm Psychol , vol.114 , Issue.4 , pp. 599-611
    • Lee, J.1    Park, S.2
  • 44
    • 18544372627 scopus 로고    scopus 로고
    • Beyond hypofrontality: A quantitative meta-analysis of functional neuroimaging studies of working memory in schizophrenia
    • Glahn DC, Ragland JD, Abramoff A, et al. Beyond hypofrontality: a quantitative meta-analysis of functional neuroimaging studies of working memory in schizophrenia. Hum Brain Mapp 2005; 25(1): 60-9
    • (2005) Hum Brain Mapp , vol.25 , Issue.1 , pp. 60-69
    • Glahn, D.C.1    Ragland, J.D.2    Abramoff, A.3
  • 45
    • 58149396518 scopus 로고    scopus 로고
    • Neural correlates of executive function and working memory in the 'at-risk mental state'
    • Broome MR, Matthiasson P, Fusar-Poli P, et al. Neural correlates of executive function and working memory in the 'at-risk mental state'. Br J Psychiatry 2009; 194(1): 25-33
    • (2009) Br J Psychiatry , vol.194 , Issue.1 , pp. 25-33
    • Broome, M.R.1    Matthiasson, P.2    Fusar-Poli, P.3
  • 46
    • 36048948939 scopus 로고    scopus 로고
    • Neuropsychological deficits in individuals with an at risk mental state for psychosis - working memory as a potential trait marker
    • Pflueger MO, Gschwandtner U, Stieglitz RD, Riecher-Rossler A. Neuropsychological deficits in individuals with an at risk mental state for psychosis - working memory as a potential trait marker. Schizophr Res 2007; 97(1-3): 14-24
    • (2007) Schizophr Res , vol.97 , Issue.1-3 , pp. 14-24
    • Pflueger, M.O.1    Gschwandtner, U.2    Stieglitz, R.D.3    Riecher-Rossler, A.4
  • 48
    • 34147160638 scopus 로고    scopus 로고
    • Neurocognitive indicators for a conversion to psychosis: Comparison of patients in a potentially initial prodromal state who did or did not convert to a psychosis
    • Pukrop R, Ruhrmann S, Schultze-Lutter F, Bechdolf A, Brockhaus-Dumke A, Klosterkotter J. Neurocognitive indicators for a conversion to psychosis: comparison of patients in a potentially initial prodromal state who did or did not convert to a psychosis. Schizophr Res 2007; 92(1-3): 116-25.
    • (2007) Schizophr Res , vol.92 , Issue.1-3 , pp. 116-125
    • Pukrop, R.1    Ruhrmann, S.2    Schultze-Lutter, F.3    Bechdolf, A.4    Brockhaus-Dumke, A.5    Klosterkotter, J.6
  • 49
    • 2342597739 scopus 로고    scopus 로고
    • Neuroimaging studies of working memory: A meta-analysis
    • Wager TD, Smith EE. Neuroimaging studies of working memory: a meta-analysis. Cogn Affect Behav Neurosci 2003; 3(4): 255-74
    • (2003) Cogn Affect Behav Neurosci , vol.3 , Issue.4 , pp. 255-274
    • Wager, T.D.1    Smith, E.E.2
  • 50
    • 18544382706 scopus 로고    scopus 로고
    • N-back working memory paradigm: A meta-analysis of normative functional neuroimaging studies
    • Owen AM, McMillan KM, Laird AR, Bullmore E. N-back working memory paradigm: a meta-analysis of normative functional neuroimaging studies. Hum Brain Mapp 2005; 25(1): 46-59
    • (2005) Hum Brain Mapp , vol.25 , Issue.1 , pp. 46-59
    • Owen, A.M.1    McMillan, K.M.2    Laird, A.R.3    Bullmore, E.4
  • 51
    • 67649487922 scopus 로고    scopus 로고
    • The dopaminergic basis of human behaviors: A review of molecular imaging studies
    • Egerton A, Mehta MA, Montgomery AJ, et al. The dopaminergic basis of human behaviors: A review of molecular imaging studies. Neurosci Biobehav Rev 2009; 33(7): 1109-32.
    • (2009) Neurosci Biobehav Rev , vol.33 , Issue.7 , pp. 1109-1132
    • Egerton, A.1    Mehta, M.A.2    Montgomery, A.J.3
  • 52
    • 1342280335 scopus 로고    scopus 로고
    • Working memory and dopamine: Clinical and experimental clues
    • Marie RM, Defer GL. Working memory and dopamine: clinical and experimental clues. Curr Opin Neurol 2003; 16 (Suppl 2): S29-S35.
    • (2003) Curr Opin Neurol , vol.16 , Issue.SUPPL. 2
    • Marie, R.M.1    Defer, G.L.2
  • 53
    • 0037234962 scopus 로고    scopus 로고
    • Dopaminergic modulation of visual-spatial working memory in Parkinson's disease
    • Costa A, Peppe A, Dell'Agnello G, et al. Dopaminergic modulation of visual-spatial working memory in Parkinson's disease. Dement Geriatr Cogn Disord 2003; 15(2): 55-66.
    • (2003) Dement Geriatr Cogn Disord , vol.15 , Issue.2 , pp. 55-66
    • Costa, A.1    Peppe, A.2    Dell'Agnello, G.3
  • 55
    • 0030460739 scopus 로고    scopus 로고
    • Regional and cellular fractionation of working memory
    • Goldman-Rakic PS. Regional and cellular fractionation of working memory. Proc Natl Acad Sci U S A 1996; 93(24): 13473-80
    • (1996) Proc Natl Acad Sci U S A , vol.93 , Issue.24 , pp. 13473-13480
    • Goldman-Rakic, P.S.1
  • 56
    • 0036301360 scopus 로고    scopus 로고
    • Impaired learning in a spatial working memory version and in a cued version of the water maze in rats with MPTPinduced mesencephalic dopaminergic lesions
    • Miyoshi E, Wietzikoski S, Camplessei M, Silveira R, Takahashi RN, Da Cunha C. Impaired learning in a spatial working memory version and in a cued version of the water maze in rats with MPTPinduced mesencephalic dopaminergic lesions. Brain Res Bull 2002; 58(1): 41-7
    • (2002) Brain Res Bull , vol.58 , Issue.1 , pp. 41-47
    • Miyoshi, E.1    Wietzikoski, S.2    Camplessei, M.3    Silveira, R.4    Takahashi, R.N.5    da Cunha, C.6
  • 57
    • 33645873908 scopus 로고    scopus 로고
    • Under the curve: Critical issues for elucidating D1 receptor function in working memory
    • Williams GV, Castner SA. Under the curve: critical issues for elucidating D1 receptor function in working memory. Neuroscience 2006; 139(1): 263-76.
    • (2006) Neuroscience , vol.139 , Issue.1 , pp. 263-276
    • Williams, G.V.1    Castner, S.A.2
  • 58
    • 77954470531 scopus 로고    scopus 로고
    • Abnormal frontostriatal interactions in people with prodromal signs of psychosis: A multimodal imaging study
    • Fusar-Poli P, Howes OD, Allen P, et al. Abnormal frontostriatal interactions in people with prodromal signs of psychosis: a multimodal imaging study. Arch Gen Psychiatry 2010; 67(7): 683-691
    • (2010) Arch Gen Psychiatry , vol.67 , Issue.7 , pp. 683-691
    • Fusar-Poli, P.1    Howes, O.D.2    Allen, P.3
  • 60
    • 0036177183 scopus 로고    scopus 로고
    • Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia
    • Meyer-Lindenberg A, Miletich RS, Kohn PD, et al. Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia. Nat Neurosci 2002; 5(3): 267-71.
    • (2002) Nat Neurosci , vol.5 , Issue.3 , pp. 267-271
    • Meyer-Lindenberg, A.1    Miletich, R.S.2    Kohn, P.D.3
  • 61
    • 0034142382 scopus 로고    scopus 로고
    • The relationship between dorsolateral prefrontal neuronal N-acetylaspartate and evoked release of striatal dopamine in schizophrenia
    • Bertolino A, Breier A, Callicott JH, et al. The relationship between dorsolateral prefrontal neuronal N-acetylaspartate and evoked release of striatal dopamine in schizophrenia. Neuropsychopharmacology 2000; 22(2): 125-32.
    • (2000) Neuropsychopharmacology , vol.22 , Issue.2 , pp. 125-132
    • Bertolino, A.1    Breier, A.2    Callicott, J.H.3
  • 62
    • 3042748173 scopus 로고    scopus 로고
    • Neonatal medial prefrontal cortex lesion enhances the sensitivity of the mesoaccumbal dopamine system
    • Bennay M, Gernert M, Schwabe K, Enkel T, Koch M. Neonatal medial prefrontal cortex lesion enhances the sensitivity of the mesoaccumbal dopamine system. Eur J Neurosci 2004; 19(12): 3277-90
    • (2004) Eur J Neurosci , vol.19 , Issue.12 , pp. 3277-3290
    • Bennay, M.1    Gernert, M.2    Schwabe, K.3    Enkel, T.4    Koch, M.5
  • 63
    • 0029830782 scopus 로고    scopus 로고
    • Enhanced amphetamine sensitivity and increased expression of dopamine D2 receptors in postpubertal rats after neonatal excitotoxic lesions of the medial prefrontal cortex
    • Flores G, Wood GK, Liang JJ, Quirion R, Srivastava LK. Enhanced amphetamine sensitivity and increased expression of dopamine D2 receptors in postpubertal rats after neonatal excitotoxic lesions of the medial prefrontal cortex. J Neurosci 1996; 16(22): 7366-75
    • (1996) J Neurosci , vol.16 , Issue.22 , pp. 7366-7375
    • Flores, G.1    Wood, G.K.2    Liang, J.J.3    Quirion, R.4    Srivastava, L.K.5
  • 64
    • 32344435859 scopus 로고    scopus 로고
    • Transient and selective overexpression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning
    • Kellendonk C, Simpson EH, Polan HJ, et al. Transient and selective overexpression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning. Neuron 2006; 49(4): 603-15
    • (2006) Neuron , vol.49 , Issue.4 , pp. 603-615
    • Kellendonk, C.1    Simpson, E.H.2    Polan, H.J.3
  • 65
    • 77956934157 scopus 로고    scopus 로고
    • Altered relationship between hippocampal glutamate levels and striatal dopamine function in subjects at ultra high risk of psychosis
    • Stone JM, Howes OD, Egerton A, et al. Altered relationship between hippocampal glutamate levels and striatal dopamine function in subjects at ultra high risk of psychosis. Biol Psychiatry 2010; 68(7): 599-602
    • (2010) Biol Psychiatry , vol.68 , Issue.7 , pp. 599-602
    • Stone, J.M.1    Howes, O.D.2    Egerton, A.3
  • 66
    • 44249121941 scopus 로고    scopus 로고
    • Abnormal P300 in people with high risk of developing psychosis
    • Bramon E, Shaikh M, Broome M, et al. Abnormal P300 in people with high risk of developing psychosis. Neuroimage 2008; 41(2): 553-60
    • (2008) Neuroimage , vol.41 , Issue.2 , pp. 553-560
    • Bramon, E.1    Shaikh, M.2    Broome, M.3
  • 67
    • 78651058525 scopus 로고
    • An antiserotonin which is active when fed
    • Woolley DW, Shaw E. An antiserotonin which is active when fed. J Pharmacol Exp Ther 1953; 108(1): 87-93
    • (1953) J Pharmacol Exp Ther , vol.108 , Issue.1 , pp. 87-93
    • Woolley, D.W.1    Shaw, E.2
  • 68
    • 84960994447 scopus 로고
    • Antagonism between lysergic acid diethylamide and 5- hydroxytryptamine
    • Gaddum JH. Antagonism between lysergic acid diethylamide and 5- hydroxytryptamine. J Physiol 1953; 121(1): 15P
    • (1953) J Physiol , vol.121 , Issue.1 , pp. 15
    • Gaddum, J.H.1
  • 69
    • 77049189428 scopus 로고
    • The distribution of substance P and 5-hydroxytryptamine in the central nervous system of the dog
    • Amin AH, Crawford TB, Gaddum JH. The distribution of substance P and 5-hydroxytryptamine in the central nervous system of the dog. J Physiol. 1954; 126(3): 596-618
    • (1954) J Physiol , vol.126 , Issue.3 , pp. 596-618
    • Amin, A.H.1    Crawford, T.B.2    Gaddum, J.H.3
  • 70
    • 0034055690 scopus 로고    scopus 로고
    • Serotonin model of schizophrenia: Emerging role of glutamate mechanisms
    • Aghajanian GK, Marek GJ. Serotonin model of schizophrenia: emerging role of glutamate mechanisms. Brain Res Brain Res Rev 2000; 31(2-3): 302-12
    • (2000) Brain Res Brain Res Rev , vol.31 , Issue.2-3 , pp. 302-312
    • Aghajanian, G.K.1    Marek, G.J.2
  • 71
    • 0024468417 scopus 로고
    • Clinical studies on the mechanism of action of clozapine: The dopamine-serotonin hypothesis of schizophrenia
    • Meltzer HY. Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia. Psychopharmacology (Berl) 1989; 99 (Suppl): S18-27
    • (1989) Psychopharmacology (Berl) , vol.99 , Issue.SUPPL
    • Meltzer, H.Y.1
  • 73
    • 0036119338 scopus 로고    scopus 로고
    • Molecular, pharmacological and functional diversity of 5-HT receptors
    • Hoyer D, Hannon JP, Martin GR. Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav 2002; 71(4): 533-54
    • (2002) Pharmacol Biochem Behav , vol.71 , Issue.4 , pp. 533-554
    • Hoyer, D.1    Hannon, J.P.2    Martin, G.R.3
  • 74
    • 73649110630 scopus 로고    scopus 로고
    • Decreased frontal serotonin2A receptor binding in antipsychotic-naive patients with first-episode schizophrenia
    • Rasmussen H, Erritzoe D, Andersen R, et al. Decreased frontal serotonin2A receptor binding in antipsychotic-naive patients with first-episode schizophrenia. Arch Gen Psychiatry 2010; 67(1): 9-16.
    • (2010) Arch Gen Psychiatry , vol.67 , Issue.1 , pp. 9-16
    • Rasmussen, H.1    Erritzoe, D.2    Andersen, R.3
  • 75
    • 0032589898 scopus 로고    scopus 로고
    • Serotonin 5-HT2 receptors in schizophrenia: A PET study using [18F]setoperone in neurolepticnaive patients and normal subjects
    • Lewis R, Kapur S, Jones C, et al. Serotonin 5-HT2 receptors in schizophrenia: a PET study using [18F]setoperone in neurolepticnaive patients and normal subjects. Am J Psychiatry 1999; 156(1): 72-8
    • (1999) Am J Psychiatry , vol.156 , Issue.1 , pp. 72-78
    • Lewis, R.1    Kapur, S.2    Jones, C.3
  • 76
    • 0032481931 scopus 로고    scopus 로고
    • No serotonin 5-HT2A receptor density abnormality in the cortex of schizophrenic patients studied with PET
    • Trichard C, Paillere-Martinot ML, Attar-Levy D, Blin J, Feline A, Martinot JL. No serotonin 5-HT2A receptor density abnormality in the cortex of schizophrenic patients studied with PET. Schizophr Res 1998; 31(1): 13-7.
    • (1998) Schizophr Res , vol.31 , Issue.1 , pp. 13-17
    • Trichard, C.1    Paillere-Martinot, M.L.2    Attar-Levy, D.3    Blin, J.4    Feline, A.5    Martinot, J.L.6
  • 77
    • 0034640058 scopus 로고    scopus 로고
    • Serotonin 5-HT2 receptors in schizophrenic patients studied by positron emission tomography
    • Okubo Y, Suhara T, Suzuki K, et al. Serotonin 5-HT2 receptors in schizophrenic patients studied by positron emission tomography. Life Sci 2000; 66(25): 2455-64
    • (2000) Life Sci , vol.66 , Issue.25 , pp. 2455-2464
    • Okubo, Y.1    Suhara, T.2    Suzuki, K.3
  • 78
    • 49549118726 scopus 로고    scopus 로고
    • Cortical and subcortical 5-HT2A receptor binding in neuroleptic-naive firstepisode schizophrenic patients
    • Erritzoe D, Rasmussen H, Kristiansen KT, et al. Cortical and subcortical 5-HT2A receptor binding in neuroleptic-naive firstepisode schizophrenic patients. Neuropsychopharmacology 2008; 33(10): 2435-41.
    • (2008) Neuropsychopharmacology , vol.33 , Issue.10 , pp. 2435-2441
    • Erritzoe, D.1    Rasmussen, H.2    Kristiansen, K.T.3
  • 79
    • 0034051207 scopus 로고    scopus 로고
    • Decreased serotonin 2A receptor densities in neuroleptic-naive patients with schizophrenia: A PET study using [(18)F]setoperone
    • Ngan ET, Yatham LN, Ruth TJ, Liddle PF. Decreased serotonin 2A receptor densities in neuroleptic-naive patients with schizophrenia: A PET study using [(18)F]setoperone. Am J Psychiatry 2000; 157(6): 1016-8
    • (2000) Am J Psychiatry , vol.157 , Issue.6 , pp. 1016-1018
    • Ngan, E.T.1    Yatham, L.N.2    Ruth, T.J.3    Liddle, P.F.4
  • 80
    • 36349009767 scopus 로고    scopus 로고
    • 5-HT2A receptor density is decreased in the at-risk mental state
    • Hurlemann R, Matusch A, Kuhn KU, et al. 5-HT2A receptor density is decreased in the at-risk mental state. Psychopharmacology (Berl) 2008; 195(4): 579-90
    • (2008) Psychopharmacology (Berl) , vol.195 , Issue.4 , pp. 579-590
    • Hurlemann, R.1    Matusch, A.2    Kuhn, K.U.3
  • 81
    • 0036270010 scopus 로고    scopus 로고
    • Brain serotonin 5-HT(1A) receptor binding in schizophrenia measured by positron emission tomography and [11C]WAY-100635
    • Tauscher J, Kapur S, Verhoeff NP, et al. Brain serotonin 5-HT(1A) receptor binding in schizophrenia measured by positron emission tomography and [11C]WAY-100635. Arch Gen Psychiatry 2002; 59(6): 514-20
    • (2002) Arch Gen Psychiatry , vol.59 , Issue.6 , pp. 514-520
    • Tauscher, J.1    Kapur, S.2    Verhoeff, N.P.3
  • 83
    • 33750610322 scopus 로고    scopus 로고
    • Serotonin 1A receptor availability in patients with schizophrenia and schizo-affective disorder: A positron emission tomography imaging study with [11C]WAY 100635
    • Frankle WG, Lombardo I, Kegeles LS, et al. Serotonin 1A receptor availability in patients with schizophrenia and schizo-affective disorder: a positron emission tomography imaging study with [11C]WAY 100635. Psychopharmacology (Berl) 2006; 189(2): 155-64.
    • (2006) Psychopharmacology (Berl) , vol.189 , Issue.2 , pp. 155-164
    • Frankle, W.G.1    Lombardo, I.2    Kegeles, L.S.3
  • 84
    • 6344288788 scopus 로고    scopus 로고
    • A positron emission tomography study of the 5-HT1A receptor in schizophrenia and during clozapine treatment
    • Bantick RA, Montgomery AJ, Bench CJ, et al. A positron emission tomography study of the 5-HT1A receptor in schizophrenia and during clozapine treatment. J Psychopharmacol 2004; 18(3): 346-54.
    • (2004) J Psychopharmacol , vol.18 , Issue.3 , pp. 346-354
    • Bantick, R.A.1    Montgomery, A.J.2    Bench, C.J.3
  • 86
    • 0033952193 scopus 로고    scopus 로고
    • Dopamine and serotonin transporters in patients with schizophrenia: An imaging study with [(123)I]beta-CIT
    • Laruelle M, Abi-Dargham A, van Dyck C, et al. Dopamine and serotonin transporters in patients with schizophrenia: an imaging study with [(123)I]beta-CIT. Biol Psychiatry 2000; 47(5): 371-9.
    • (2000) Biol Psychiatry , vol.47 , Issue.5 , pp. 371-379
    • Laruelle, M.1    Abi-Dargham, A.2    van Dyck, C.3
  • 87
    • 0028850552 scopus 로고
    • Glutamate receptor dysfunction and schizophrenia
    • Olney JW, Farber NB. Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry 1995; 52(12): 998-1007.
    • (1995) Arch Gen Psychiatry , vol.52 , Issue.12 , pp. 998-1007
    • Olney, J.W.1    Farber, N.B.2
  • 88
    • 33747336232 scopus 로고    scopus 로고
    • Towards NR2B receptor selective imaging agents for PET-synthesis and evaluation of N- [11C]-(2-methoxy)benzyl (E)-styrene-, 2-naphthyl- and 4- trifluoromethoxyphenylamidine
    • Arstad E, Platzer S, Berthele A, et al. Towards NR2B receptor selective imaging agents for PET-synthesis and evaluation of N- [11C]-(2-methoxy)benzyl (E)-styrene-, 2-naphthyl- and 4- trifluoromethoxyphenylamidine. Bioorg Med Chem 2006; 14(18): 6307-13.
    • (2006) Bioorg Med Chem , vol.14 , Issue.18 , pp. 6307-6313
    • Arstad, E.1    Platzer, S.2    Berthele, A.3
  • 89
    • 79954937158 scopus 로고    scopus 로고
    • Imaging changes in glutamate transmission in vivo with the metabotropic glutamate receptor 5 tracer [11C] ABP688 and N-acetylcysteine challenge
    • Miyake N, Skinbjerg M, Easwaramoorthy B, et al. Imaging changes in glutamate transmission in vivo with the metabotropic glutamate receptor 5 tracer [11C] ABP688 and N-acetylcysteine challenge. Biol Psychiatry 2011; 69(9): 822-4.
    • (2011) Biol Psychiatry , vol.69 , Issue.9 , pp. 822-824
    • Miyake, N.1    Skinbjerg, M.2    Easwaramoorthy, B.3
  • 90
    • 0034066633 scopus 로고    scopus 로고
    • Microglia dysfunction in schizophrenia: An integrative theory
    • Munn NA. Microglia dysfunction in schizophrenia: an integrative theory. Med Hypotheses 2000; 54(2): 198-202.
    • (2000) Med Hypotheses , vol.54 , Issue.2 , pp. 198-202
    • Munn, N.A.1
  • 91
    • 0033588276 scopus 로고    scopus 로고
    • Evidence for activation of microglia in patients with psychiatric illnesses
    • Aug 20
    • Bayer TA, Buslei R, Havas L, Falkai P. Evidence for activation of microglia in patients with psychiatric illnesses. Neurosci Lett 1999 Aug 20; 271(2): 126-8.
    • (1999) Neurosci Lett , vol.271 , Issue.2 , pp. 126-128
    • Bayer, T.A.1    Buslei, R.2    Havas, L.3    Falkai, P.4
  • 92
    • 0033983020 scopus 로고    scopus 로고
    • Increase in HLA-DR immunoreactive microglia in frontal and temporal cortex of chronic schizophrenics
    • Radewicz K, Garey LJ, Gentleman SM, Reynolds R. Increase in HLA-DR immunoreactive microglia in frontal and temporal cortex of chronic schizophrenics. J Neuropathol Exp Neurol 2000; 59(2): 137-50
    • (2000) J Neuropathol Exp Neurol , vol.59 , Issue.2 , pp. 137-150
    • Radewicz, K.1    Garey, L.J.2    Gentleman, S.M.3    Reynolds, R.4
  • 93
    • 53249144430 scopus 로고    scopus 로고
    • Microglia activation in recent-onset schizophrenia: A quantitative (R)- [11C]PK11195 positron emission tomography study
    • van Berckel BN, Bossong MG, Boellaard R, et al. Microglia activation in recent-onset schizophrenia: a quantitative (R)- [11C]PK11195 positron emission tomography study. Biol Psychiatry 2008; 64(9): 820-2.
    • (2008) Biol Psychiatry , vol.64 , Issue.9 , pp. 820-822
    • van Berckel, B.N.1    Bossong, M.G.2    Boellaard, R.3
  • 94
    • 61849179511 scopus 로고    scopus 로고
    • Therapeutic signposts: Using biomarkers to guide better treatment of schizophrenia and other psychotic disorders
    • Banati R, Hickie IB. Therapeutic signposts: using biomarkers to guide better treatment of schizophrenia and other psychotic disorders. Med J Aust 2009; 190(4 Suppl): S26-32
    • (2009) Med J Aust , vol.190 , Issue.4 SUPPL
    • Banati, R.1    Hickie, I.B.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.